<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35632776</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>13</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Impaired Vagal Activity in Long-COVID-19 Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1035</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14051035</ELocationID><Abstract><AbstractText>Long-COVID-19 refers to the signs and symptoms that continue or develop after the &#x201c;acute COVID-19&#x201d; phase. These patients have an increased risk of multiorgan dysfunction, readmission, and mortality. In Long-COVID-19 patients, it is possible to detect a persistent increase in D-Dimer, NT-ProBNP, and autonomic nervous system dysfunction. To verify the dysautonomia hypothesis in Long-COVID-19 patients, we studied heart rate variability using 12-lead 24-h ECG monitoring in 30 Long-COVID-19 patients and 20 No-COVID patients. Power spectral analysis of heart rate variability was lower in Long-COVID-19 patients both for total power (7.46 &#xb1; 0.5 vs. 8.08 &#xb1; 0.6; p &lt; 0.0001; Cohens-d = 1.12) and for the VLF (6.84 &#xb1; 0.8 vs. 7.66 &#xb1; 0.6; p &lt; 0.0001; Cohens-d = 1.16) and HF (4.65 &#xb1; 0.9 vs. 5.33 &#xb1; 0.9; p = 0.015; Cohens-d = 0.76) components. The LF/HF ratio was significantly higher in Long-COVID-19 patients (1.46 &#xb1; 0.27 vs. 1.23 &#xb1; 0.13; p = 0.001; Cohens-d = 1.09). On multivariable analysis, Long-COVID-19 is significantly correlated with D-dimer (standardized &#x3b2;-coefficient = 0.259), NT-ProBNP (standardized &#x3b2;-coefficient = 0.281), HF component of spectral analysis (standardized &#x3b2;-coefficient = 0.696), and LF/HF ratio (standardized &#x3b2;-coefficient = 0.820). Dysautonomia may explain the persistent symptoms in Long COVID-19 patients. The persistence of a procoagulative state and an elevated myocardial strain could explain vagal impairment in these patients. In Long-COVID-19 patients, impaired vagal activity, persistent increases of NT-ProBNP, and a prothrombotic state require careful monitoring and appropriate intervention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Acanfora</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, San Francesco Hospital, Viale Europa 21, 82037 Telese Terme, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nolano</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II of Naples, 80131 Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Department, Skin Biopsy Laboratory, Istituti Clinici Scientifici Maugeri IRCCS, 82037 Telese Terme, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acanfora</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1701-8277</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, San Francesco Hospital, Viale Europa 21, 82037 Telese Terme, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biotechnological and Applied Clinical Science, University of L'Aquila, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colella</LastName><ForeName>Camillo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, San Francesco Hospital, Viale Europa 21, 82037 Telese Terme, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Provitera</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Neurology Department, Skin Biopsy Laboratory, Istituti Clinici Scientifici Maugeri IRCCS, 82037 Telese Terme, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caporaso</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neurology Department, Skin Biopsy Laboratory, Istituti Clinici Scientifici Maugeri IRCCS, 82037 Telese Terme, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodolico</LastName><ForeName>Gabriele Rosario</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Careggi University Hospital, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bortone</LastName><ForeName>Alessandro Santo</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galasso</LastName><ForeName>Gennaro</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7265-7613</Identifier><AffiliationInfo><Affiliation>Department of Medicine Surgery and Dentistry, University of Salerno, 84121 Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casucci</LastName><ForeName>Gerardo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, San Francesco Hospital, Viale Europa 21, 82037 Telese Terme, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054969" MajorTopicYN="Y">Primary Dysautonomias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">D-dimer</Keyword><Keyword MajorTopicYN="N">Long-COVID-19</Keyword><Keyword MajorTopicYN="N">NT-ProBNP</Keyword><Keyword MajorTopicYN="N">dysautonomia hypothesis</Keyword><Keyword MajorTopicYN="N">heart rate variability</Keyword><Keyword MajorTopicYN="N">procoagulative state</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35632776</ArticleId><ArticleId IdType="pmc">PMC9147759</ArticleId><ArticleId IdType="doi">10.3390/v14051035</ArticleId><ArticleId IdType="pii">v14051035</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-COVID syndrome in individuals admitted to hospital with covid-19: Retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long-term effects of COVID-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., Jacob J., ARC Study Group et al. &#x2018;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalization for COVID-19. Thorax. 2021;76:396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Fogarty H., Dyer A., Martin-Loeches I., Bannan C., Nadarajan P., Bergin C., O&#x2019;Farrelly C., Conlon N., Bourke N.M., et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J. Thromb. Haemost. 2021;19:1064&#x2013;1070. doi: 10.1111/jth.15267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Acanfora D., Acanfora C., Ciccone M.M., Scicchitano P., Bortone A.S., Uguccioni M., Casucci G. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases. Viruses. 2021;13:1904. doi: 10.3390/v13101904.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13101904</ArticleId><ArticleId IdType="pmc">PMC8540492</ArticleId><ArticleId IdType="pubmed">34696334</ArticleId></ArticleIdList></Reference><Reference><Citation>Barizien N., Le Guen M., Russel S., Touche P., Huang F., Vall&#xe9;e A. Clinical characterization of dysautonomia in long COVID-19 patients. Sci. Rep. 2021;7:14042. doi: 10.1038/s41598-021-93546-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93546-5</ArticleId><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigger J.T., Jr., Fleiss J.L., Steinman R.C., Rolnitzky L.M., Kleiger R.E., Rottman J.N. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 1992;85:164&#x2013;171. doi: 10.1161/01.CIR.85.1.164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.85.1.164</ArticleId><ArticleId IdType="pubmed">1728446</ArticleId></ArticleIdList></Reference><Reference><Citation>Task Force of the European Society of Cardiology. The North American Society of Pacing and Electrophysiology Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043&#x2013;1065. doi: 10.1161/01.CIR.93.5.1043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.93.5.1043</ArticleId><ArticleId IdType="pubmed">8598068</ArticleId></ArticleIdList></Reference><Reference><Citation>Takabatake N., Nakamura H., Minamihaba O., Inage M., Inoue S., Kagaya S., Yamaki M., Tomoike H. A novel pathophysiologic phenomenon in cachexic patients with chronic obstructive pulmonary disease: The relationship between the circadian rhythm of circulating leptin and the very low-frequency component of heart rate variability. Am. J. Respir. Crit. Care Med. 2001;163:1314&#x2013;1319. doi: 10.1164/ajrccm.163.6.2004175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.163.6.2004175</ArticleId><ArticleId IdType="pubmed">11371394</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinik A.I., Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387&#x2013;397. doi: 10.1161/CIRCULATIONAHA.106.634949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.634949</ArticleId><ArticleId IdType="pubmed">17242296</ArticleId></ArticleIdList></Reference><Reference><Citation>Marvar P.J., Harrison D.G. Inflammation, immunity and the autonomic nervous system. In: Robertson D., Biaggioni I., Burnstock G., Low P.A., Paton J.F.R., editors. Primer on the Autonomic Nervous System. Elsevier; Amsterdam, The Netherlands: 2012. pp. 325&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-386525-0.00067-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2021. Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>De Terwangne C., Laouni J., Jouffe L., Lechien J., Bouillon V., Place S., Capulzini L., Machayekhi S., Ceccarelli A., Saussez S., et al. Predictive Accuracy of COVID-19 World Health Organization (WHO) Severity Classification and Comparison with a Bayesian-Method-Based Severity Score (EPI-SCORE) Pathogens. 2020;9:880. doi: 10.3390/pathogens9110880.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9110880</ArticleId><ArticleId IdType="pmc">PMC7692702</ArticleId><ArticleId IdType="pubmed">33114416</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Boon G.J., Barco S., Endres M., Geelhoed J.M., Knauss S., Rezek S.A., Spruit M.A., Vehreschild J., Siegerink B. The Post-COVID-19 Functional Status scale: A tool to measure functional status over time after COVID-19. Eur. Respir. J. 2020;56:2001494. doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli Incalzi R., Corsonello A., Trojano L., Pedone C., Acanfora D., Spada A., D&#x2019;Addio G., Maestri R., Rengo F., Rengo G. Heart rate variability and drawing impairment in hypoxemic COPD. Brain Cogn. 2009;70:163&#x2013;170. doi: 10.1016/j.bandc.2009.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bandc.2009.01.010</ArticleId><ArticleId IdType="pubmed">19261365</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Lawrence Erlbaum Associates; New York, NY, USA: Hillsdale, NJ, USA: 1988.</Citation></Reference><Reference><Citation>R Core Team  . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; Vienna, Austria: 2013.  [(accessed on 30 September 2021)].  Available online:  http://www.R-project.org/</Citation></Reference><Reference><Citation>Pel&#xe0; G., Goldoni M., Solinas E., Cavalli C., Tagliaferri S., Ranzieri S., Frizzelli A., Marchi L., Mori P.A., Majori M., et al. Sex-Related Differences in Long-COVID-19 Syndrome. J. Womens Health. 2022 doi: 10.1089/jwh.2021.0411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2021.0411</ArticleId><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference><Reference><Citation>Swai J., Hu Z., Zhao X., Rugambwa T., Ming G. Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome versus healthy participants; a systematic review and meta-analysis. BMC Cardiovasc. Disord. 2019;19:320. doi: 10.1186/s12872-019-01298-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-019-01298-y</ArticleId><ArticleId IdType="pmc">PMC6936126</ArticleId><ArticleId IdType="pubmed">31888497</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L.C., Lely A.T., Navis G.V., van Goor H. Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Achar A., Ghosh C. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance. Cells. 2020;9:2360. doi: 10.3390/cells9112360.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112360</ArticleId><ArticleId IdType="pmc">PMC7692725</ArticleId><ArticleId IdType="pubmed">33120941</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenrich M., Mrdenovic S., Balog M., Tomic S., Zjalic M., Roncevic A., Mandic D., Debeljak Z., Heffer M. SARS-CoV-2 Dissemination Through Peripheral Nerves Explains Multiple Organ Injury. Front. Cell. Neurosci. 2020;14:229. doi: 10.3389/fncel.2020.00229.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00229</ArticleId><ArticleId IdType="pmc">PMC7419602</ArticleId><ArticleId IdType="pubmed">32848621</ArticleId></ArticleIdList></Reference><Reference><Citation>Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., et al. A Novel Angiotensin-Converting Enzyme&#x2013;Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9. Circ. Res. 2000;87:e1&#x2013;e9. doi: 10.1161/01.RES.87.5.e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.87.5.e1</ArticleId><ArticleId IdType="pubmed">10969042</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowrisankar Y.V., Clar M.A. Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures. J. Neurochem. 2016;138:74&#x2013;85. doi: 10.1111/jnc.13641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13641</ArticleId><ArticleId IdType="pubmed">27085714</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Lazartigues E. Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function. Curr. Hypertens. Rep. 2010;12:170&#x2013;175. doi: 10.1007/s11906-010-0105-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-010-0105-7</ArticleId><ArticleId IdType="pmc">PMC3093757</ArticleId><ArticleId IdType="pubmed">20424953</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N., Ashton N.J., Andersson L.M., Yilmaz A., Lindh M., Nilsson S., Price R.W., Blennow K., Zetterberg H., Gissl&#xe9;n M. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95:e1754&#x2013;e1759. doi: 10.1212/WNL.0000000000010111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010111</ArticleId><ArticleId IdType="pubmed">32546655</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariotto S., Savoldi A., Donadello K., Zanzoni S., Bozzetti S., Carta S., Zivelonghi C., Alberti D., Piraino F., Minuz P., et al. Nervous system: Subclinical target of SARS-CoV-2 infection. J. Neurol. Neurosurg. Psychiatry. 2020;91:1010&#x2013;1012. doi: 10.1136/jnnp-2020-323881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323881</ArticleId><ArticleId IdType="pmc">PMC7476308</ArticleId><ArticleId IdType="pubmed">32576611</ArticleId></ArticleIdList></Reference><Reference><Citation>Reza-Zald&#xed;var E.E., Hern&#xe1;ndez-Sapi&#xe9;ns M.A., Minjarez B., G&#xf3;mez-Pinedo U., M&#xe1;rquez-Aguirre A.L., Mateos-D&#xed;az J.C., Matias-Guiu J., Canales-Aguirre A.A. Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System. Front. Immunol. 2021;11:621735. doi: 10.3389/fimmu.2020.621735.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.621735</ArticleId><ArticleId IdType="pmc">PMC7878381</ArticleId><ArticleId IdType="pubmed">33584720</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulfamante G., Bocci T., Falleni M., Campiglio L., Coppola S., Tosi D., Chiumello D., Priori A. Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung. J. Neurol. 2021;268:4486&#x2013;4491. doi: 10.1007/s00415-021-10604-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10604-8</ArticleId><ArticleId IdType="pmc">PMC8129960</ArticleId><ArticleId IdType="pubmed">34003372</ArticleId></ArticleIdList></Reference><Reference><Citation>Caro-Cod&#xf3;n J., Rey J.R., Bu&#xf1;o A., Iniesta A.M., Rosillo S.O., Castrejon-Castrejon S., Rodriguez-Sotelo L., Martinez L.A., Marco I., Merino C., et al. CARD-COVID Investigators. Characterization of NT-proBNP in a large cohort of COVID-19 patients. Eur. J. Heart Fail. 2021;23:456&#x2013;464. doi: 10.1002/ejhf.2095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2095</ArticleId><ArticleId IdType="pmc">PMC8013330</ArticleId><ArticleId IdType="pubmed">33421281</ArticleId></ArticleIdList></Reference><Reference><Citation>Acanfora D., Scicchitano P., Acanfora C., Maestri R., Goglia F., Incalzi R.A., Bortone A.S., Ciccone M.M., Uguccioni M., Casucci G. Early Initiation of Sacubitril/Valsartan in Patients with Chronic Heart Failure After Acute Decompensation: A Case Series Analysis. Clin. Drug Investig. 2020;40:493&#x2013;501. doi: 10.1007/s40261-020-00908-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40261-020-00908-4</ArticleId><ArticleId IdType="pubmed">32193801</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T., Fan Y., Chen M., Wu X., Zhang L., He T., Wang H., Wan J., Wang X., Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:811&#x2013;818. doi: 10.1001/jamacardio.2020.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wang Z., Tse G., Zhang L., Wan E.Y., Guo Y., Lip G.Y.H., Li G., Lu Z., Liu T. Cardiac arrhythmias in patients with COVID-19. J. Arrhythm. 2020;36:827&#x2013;836. doi: 10.1002/joa3.12405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/joa3.12405</ArticleId><ArticleId IdType="pmc">PMC7532267</ArticleId><ArticleId IdType="pubmed">33024460</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A., Pallar&#xe9;s J.G., Buend&#xed;a-Romero &#xc1;., Mart&#xed;nez-Cava A., Courel-Ib&#xe1;&#xf1;ez J. Chronotropic Incompetence in Non-Hospitalized Patients with Post-COVID-19 Syndrome. J. Clin. Med. 2021;10:5434. doi: 10.3390/jcm10225434.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10225434</ArticleId><ArticleId IdType="pmc">PMC8617992</ArticleId><ArticleId IdType="pubmed">34830716</ArticleId></ArticleIdList></Reference><Reference><Citation>Acanfora C., Casucci G. Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan): Rationale for adoption in SARS-CoV-2 patients. Eur. Heart J. Cardiovasc. Pharmacother. 2020;6:135&#x2013;136. doi: 10.1093/ehjcvp/pvaa028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcvp/pvaa028</ArticleId><ArticleId IdType="pmc">PMC7184416</ArticleId><ArticleId IdType="pubmed">32282032</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>